keyword
https://read.qxmd.com/read/38652890/clonal-hematopoiesis-of-indeterminate-potential-in-patients-with-immunoglobulin-light-chain-al-amyloidosis
#1
JOURNAL ARTICLE
Paolo Lopedote, Benjamin Evans, Alfredo Marchetti, Tianzeng Chen, Maria Moscvin, Samuel Boullt, Niccolo Bolli, Giada Bianchi
Immunoglobulin light chain (AL) amyloidosis is characterized by the deposition of misfolded monoclonal free light chains, with cardiac complications accounting for patients' mortality. Clonal hematopoiesis of indeterminate potential (CHIP) has been associated with worse cardiovascular outcomes in the general population. Its significance in AL amyloidosis remains unclear. We collected clinical information and outcome data on 76 patients with a diagnosis of AL amyloidosis who underwent deep-targeted sequencing for myeloid neoplasia-associated mutations between April 2018 and August 2023...
April 23, 2024: Blood Advances
https://read.qxmd.com/read/38652858/comparison-of-safety-and-treatment-continuity-of-palbociclib-and-abemaciclib-for-hormone-receptor-positive-her2-negative-metastatic-recurrent-breast-cancer
#2
JOURNAL ARTICLE
Makiko Go, Michio Kimura, Shiori Yamada, Eiseki Usami, Yoshihiro Noguchi, Tomoaki Yoshimura
Background : Appropriate adverse event (AE) management and maintenance of therapeutic intensity are necessary to achieve therapeutic benefits of CDK4/6 inhibitors (palbociclib and abemaciclib) in hormone receptor-positive, HER2-negative metastatic/recurrent breast cancer. Objective : This study was aimed at clarifying the effect of AEs associated with palbociclib and abemaciclib on treatment. Methods : A total of 62 and 49 patients were prescribed palbociclib and abemaciclib, respectively, at our hospital from January 1, 2018 to June 30, 2023...
April 23, 2024: Journal of Pharmacy Practice
https://read.qxmd.com/read/38652731/development-and-validation-of-a-race-agnostic-computable-phenotype-for-kidney-health-in-adult-hospitalized-patients
#3
JOURNAL ARTICLE
Tezcan Ozrazgat-Baslanti, Yuanfang Ren, Esra Adiyeke, Rubab Islam, Haleh Hashemighouchani, Matthew Ruppert, Shunshun Miao, Tyler Loftus, Crystal Johnson-Mann, R W M A Madushani, Elizabeth A Shenkman, William Hogan, Mark S Segal, Gloria Lipori, Azra Bihorac, Charles Hobson
Standard race adjustments for estimating glomerular filtration rate (GFR) and reference creatinine can yield a lower acute kidney injury (AKI) and chronic kidney disease (CKD) prevalence among African American patients than non-race adjusted estimates. We developed two race-agnostic computable phenotypes that assess kidney health among 139,152 subjects admitted to the University of Florida Health between 1/2012-8/2019 by removing the race modifier from the estimated GFR and estimated creatinine formula used by the race-adjusted algorithm (race-agnostic algorithm 1) and by utilizing 2021 CKD-EPI refit without race formula (race-agnostic algorithm 2) for calculations of the estimated GFR and estimated creatinine...
2024: PloS One
https://read.qxmd.com/read/38652558/a-tryptophan-derived-uremic-metabolite-ahr-pdk4-axis-governs-skeletal-muscle-mitochondrial-energetics-in-chronic-kidney-disease
#4
JOURNAL ARTICLE
Trace Thome, Nicholas A Vugman, Lauren E Stone, Keon Wimberly, Salvatore T Scali, Terence E Ryan
Chronic kidney disease (CKD) causes an accumulation of uremic metabolites that negatively impact skeletal muscle function. Tryptophan-derived uremic metabolites are agonists of the aryl hydrocarbon receptor (AHR) which has been shown to be activated in the blood of CKD patients. This study investigated the role of the AHR in skeletal muscle pathology of CKD. Compared to control participants with normal kidney function, AHR-dependent gene expression (CYP1A1 and CYP1B1) was significantly upregulated in skeletal muscle of patients with CKD (P=0...
April 23, 2024: JCI Insight
https://read.qxmd.com/read/38652398/improvement-in-right-heart-function-following-kidney-transplantation-in-esrd-patients-insights-from-speckle-tracking-echocardiography-analysis
#5
JOURNAL ARTICLE
Mohammad Khani, Amir Moradi, Erfan Ghadirzadeh, Seyed Pooria Salehi Mashhad Sari, Tooba Akbari
Chronic kidney disease (CKD) is commonly associated with unfavorable cardiovascular outcomes and remains the leading cause of mortality in individuals with end-stage renal disease (ESRD). Despite substantial knowledge about the impact of CKD on the left heart, the right heart, which holds significant clinical relevance, has often been overlooked and inadequately assessed in ESRD patients who have undergone kidney transplant (KTx). This study aimed to evaluate the effects of KTx on the right heart chambers in ESRD patients...
April 23, 2024: International Journal of Cardiovascular Imaging
https://read.qxmd.com/read/38652382/isolated-langerhans-cell-histiocytosis-in-the-stomach-of-adults-four-case-series-and-literature-review
#6
JOURNAL ARTICLE
Jianmin Zhao, Yanlei Li, Yanlin Zhang, Xue Mei, Wei Liu, Yinghong Li
Langerhans cell histiocytosis (LCH) of the stomach is rare. Moreover, it is usually found in pediatric patients with systemic diseases and may be associated with a poor prognosis. Solitary gastric LCH in adults is extremely rare and is often misdiagnosed or missed. The aim of our study was to review cases of gastric LCH and explore the characteristics of the disease further. A retrospective study of all patients admitted with solitary gastric LCH was conducted between 2013 and 2023. Clinical manifestations, endoscopic and pathological features, immunophenotypes, and molecular changes were collected from medical records...
April 23, 2024: Journal of Hematopathology
https://read.qxmd.com/read/38652239/dipeptidyl-peptidase-4-inhibitors-vs-metformin-for-new-onset-dementia-a-propensity-score-matched-cohort-study
#7
JOURNAL ARTICLE
Siyang Liu, Heng Wan, Sheng Nie, Huanyi Cao, Lan Liu, Hua Liang, Hong Xu, Bicheng Liu, Chunbo Chen, Huafeng Liu, Qiongqiong Yang, Hua Li, Yaozhong Kong, Guisen Li, Qijun Wan, Yan Zha, Ying Hu, Gang Xu, Yongjun Shi, Yilun Zhou, Guobin Su, Ying Tang, Mengchun Gong, Aixin Guo, Jianping Weng, Hongjiang Wu, Fan Fan Hou, Jie Shen
BACKGROUND: Hypoglycemic pharmacotherapy interventions for alleviating the risk of dementia remains controversial, particularly about dipeptidyl peptidase 4 (DPP4) inhibitors versus metformin. Our objective was to investigate whether the initiation of DPP4 inhibitors, as opposed to metformin, was linked to a reduced risk of dementia. METHODS: We included individuals with type 2 diabetes over 40 years old who were new users of DPP4 inhibitors or metformin in the Chinese Renal Disease Data System (CRDS) database between 2009 and 2020...
April 23, 2024: Journal of Clinical Endocrinology and Metabolism
https://read.qxmd.com/read/38652212/the-%C3%AE-3-ar-agonist-brl37344-ameliorates-the-main-symptoms-of-x-linked-nephrogenic-diabetes-insipidus-in-the-mouse-model-of-the-disease
#8
JOURNAL ARTICLE
Serena Milano, Ilenia Saponara, Andrea Gerbino, Monica Carmosino, Maria Svelto, Giuseppe Procino
X-linked nephrogenic diabetes insipidus (X-NDI) is a rare congenital disease caused by inactivating mutations of the vasopressin type-2 receptor (AVPR2), characterized by impaired renal concentrating ability, dramatic polyuria, polydipsia and risk of dehydration. The disease, which still lacks a cure, could benefit from the pharmacologic stimulation of other GPCRs, activating the cAMP-intracellular pathway in the kidney cells expressing the AVPR2. On the basis of our previous studies, we here hypothesized that the β3-adrenergic receptor could be such an ideal candidate...
April 2024: Journal of Cellular and Molecular Medicine
https://read.qxmd.com/read/38652072/investigation-of-basolateral-targeting-micelles-for-drug-delivery-applications-in-polycystic-kidney-disease
#9
JOURNAL ARTICLE
Yi Huang, Ali Osouli, Jessica Pham, Valeria Mancino, Colette O'Grady, Taranatee Khan, Baishali Chaudhuri, Nuria M Pastor-Soler, Kenneth R Hallows, Eun Ji Chung
Autosomal dominant polycystic kidney disease (ADPKD) is a complex disorder characterized by uncontrolled renal cyst growth, leading to kidney function decline. The multifaceted nature of ADPKD suggests that single-pathway interventions using individual small molecule drugs may not be optimally effective. As such, a strategy encompassing combination therapy that addresses multiple ADPKD-associated signaling pathways could offer synergistic therapeutic results. However, severe off-targeting side effects of small molecule drugs pose a major hurdle to their clinical transition...
April 23, 2024: Biomacromolecules
https://read.qxmd.com/read/38652038/a-first-in-human-phase-1-study-of-a-tumor-directed-rna-interference-drug-against-hif2%C3%AE-in-patients-with-advanced-clear-cell-renal-cell-carcinoma
#10
JOURNAL ARTICLE
James Brugarolas, Gregory Obara, Kathryn E Beckermann, Brian Rini, Elaine T Lam, James Hamilton, Thomas Schluep, Min Yi, So Wong, Zhongping Lily Mao, Erick Gamelin, Nizar M Tannir
PURPOSE: ARO-HIF2 is an siRNA drug designed to selectively target hypoxia-inducible factor-2α (HIF2α) interrupting downstream pro-oncogenic signaling in clear cell renal cell carcinoma (ccRCC). The aims of this Phase 1 study (AROHIF21001) were to evaluate safety, tolerability, pharmacokinetics, and establish a recommended Phase 2 dose. PATIENTS AND METHODS: Subjects with ccRCC and progressive disease after at least 2 prior therapies that included VEGF and immune checkpoint inhibitors were progressively enrolled into dose-escalation cohorts of ARO-HIF2 administered intravenously at 225, 525, or 1,050 mg weekly...
April 23, 2024: Clinical Cancer Research
https://read.qxmd.com/read/38651857/pararenal-aortic-thrombus-in-patients-undergoing-aortic-aneurysm-repair-with-chimney-technique
#11
JOURNAL ARTICLE
Filippo Benedetto, Domenico Spinelli, Chiara Barillà, Alessandra Fittipaldi, Federica Maria Castellana, Giovanni De Caridi
INTRODUCTION: Chimney technique (chimney graft in abdominal aortic aneurysm repair [ChEVAR]) can be used to treat patients with pararenal aortic aneurysm unfit for open surgery and not suitable for custom-made fenestrated endograft. Since almost 1 in 5 patients undergo a reintervention within 3 years, features associated with higher risk of complications need to be investigated to tailor the follow-up schedule to each patient. The aim of our study was to assess the impact of mural thrombus in the pararenal aorta on perioperative and follow-up complications after ChEVAR...
April 23, 2024: Journal of Endovascular Therapy
https://read.qxmd.com/read/38651430/surgical-outcomes-and-complications-of-custom-made-prostheses-in-upper-limb-oncological-reconstruction-a-systematic-review
#12
REVIEW
Camillo Fulchignoni, Silvia Pietramala, Ivo Lopez, Giovan Giuseppe Mazzella, Chiara Comisi, Carlo Perisano, Lorenzo Rocchi, Tommaso Greco
Bone tumors of the upper limb are a common cause of bone pain and pathological fractures in both old and young populations. Surgical reconstruction and limb salvage have become valid options for these patients despite this kind of surgery being challenging due to the need for wide bone resection and the involvement of surrounding soft tissues. Computer-assisted technology helps the surgeon in pre-operative planning and in designing customized implants. The aim of this study was to investigate the surgical outcomes and complications of custom-made prostheses in oncologic reconstruction of the upper limb and if they are reliable options for patients suffering from aggressive tumors...
April 11, 2024: Journal of Functional Morphology and Kinesiology
https://read.qxmd.com/read/38651403/evaluation-of-renal-function-with-urinary-ngal-and-doppler-ultrasonography-in-icu-patients-a-1-year-observational-pilot-study
#13
JOURNAL ARTICLE
Etrusca Brogi, Rocco Rago, Francesco Forfori
BACKGROUND: We estimated the diagnostic accuracy of urinary NGAL for the diagnosis of AKI. METHODS: Urinary NGAL and Creatinine were measured daily for up to 3 days. Doppler ultrasonography was performed within 24 h of admission and for the following 3 days. RESULTS: Of the 21 patients, 44% had AKI during their ICU stay. The AKI group presented with higher values of serum Creatinine, renal length, MDRD as well as SAPS II already at admission...
April 3, 2024: Pathophysiology: the Official Journal of the International Society for Pathophysiology
https://read.qxmd.com/read/38651286/a-randomized-controlled-trial-to-evaluate-the-effects-of-an-early-postnatal-lifestyle-modification-program-on-diet-adiposity-and-metabolic-outcome-in-mothers-with-gestational-diabetes-mellitus
#14
JOURNAL ARTICLE
Kit Ying Tsoi, Ruth C M Chan, Cuilin Zhang, Wing Hung Tam, Ronald C W Ma
OBJECTIVE: The aim of the present study was to evaluate the effectiveness of a 12-month early postnatal lifestyle intervention program in women with gestational diabetes in a recent pregnancy. METHODS: This study was a prospective randomized intervention study conducted at a diabetes center in Hong Kong. Chinese women aged 18-45 years, who developed gestational diabetes mellitus (GDM) in their most recent pregnancy, were invited. Eligible women were randomized in 1:1 ratio at baseline (6-12 weeks postpartum), to standard care or lifestyle intervention (diet and physical activity) groups for 12 months...
April 23, 2024: International Journal of Gynaecology and Obstetrics
https://read.qxmd.com/read/38651230/buprenorphine-affects-the-initiation-and-severity-of-interleukin-induced-acute-pancreatitis-in-mice
#15
JOURNAL ARTICLE
Sarah Jahangir, Biswajit Khatua, Nabil Smichi, Prasad Rajalingamgari, Anoop Narayana Pillai, Megan J Summers, Bryce McFayden, Sergiy Kostenko, Naomi M Gades, Vijay P Singh
Acute pancreatitis (AP) is a common disease with no targeted therapy and has varied outcomes ranging from spontaneous resolution to being lethal. While typically painful, AP can also be painless. Various agents, including opioids are used for pain control in AP; the risks, and benefits of which are often debated. Since experimental AP in mice is used to study the efficacy of potential therapies, we studied the effect of a commonly used opioid buprenorphine on the initiation and progression of AP. For this we administered extended-release buprenorphine subcutaneously prior to inducing the previously established severe AP model that uses Interleukins 12 and 18 (IL12,18) in genetically obese (ob/ob) mice and compared this to mice with AP but without the drug...
April 23, 2024: American Journal of Physiology. Gastrointestinal and Liver Physiology
https://read.qxmd.com/read/38650758/validation-of-the-klinrisk-chronic-kidney-disease-progression-model-in-the-fidelity-population
#16
JOURNAL ARTICLE
Navdeep Tangri, Thomas Ferguson, Silvia J Leon, Stefan D Anker, Gerasimos Filippatos, Bertram Pitt, Peter Rossing, Luis M Ruilope, Alfredo E Farjat, Youssef M K Farag, Patrick Schloemer, Robert Lawatscheck, Katja Rohwedder, George L Bakris
BACKGROUND: Chronic kidney disease (CKD) affects >800 million individuals worldwide and is often underrecognized. Early detection, identification and treatment can delay disease progression. Klinrisk is a proprietary CKD progression risk prediction model based on common laboratory data to predict CKD progression. We aimed to externally validate the Klinrisk model for prediction of CKD progression in FIDELITY (a prespecified pooled analysis of two finerenone phase III trials in patients with CKD and type 2 diabetes)...
April 2024: Clinical Kidney Journal
https://read.qxmd.com/read/38650643/association-of-time-averaged-serum-uric-acid-level-with-clinicopathological-information-and-long-term-outcomes-in-patients-with-iga-nephropathy
#17
JOURNAL ARTICLE
Mengjie Weng, Binbin Fu, Yongjie Zhuo, Jiaqun Lin, Zhenhuan Zou, Yi Chen, Jiong Cui, Guifen Li, Caiming Chen, Yanfang Xu, Dewen Jiang, Jianxin Wan
OBJECTIVE: Whether serum uric acid (SUA) at baseline could been identiûed as a risk factor for progression in IgA nephropathy (IgAN) patients remains unclear, therefore, long- term SUA control levels must be monitored. We aimed to investigate the relevant factors affecting time-averaged SUA (TA-SUA) and to assess the prognostic value of TA-SUA in IgAN. METHODS: This retrospective study included 152 patients with IgAN. The relationships between TA-SUA and clinicopathological features and renal outcomes (defined as the doubling of the baseline serum creatinine level or end-stage renal disease) were analyzed in groups divided by quartiles of TA-SUA levels, the presence of hyperuricemia, and sex...
2024: PeerJ
https://read.qxmd.com/read/38650536/recurrent-disease-after-pediatric-renal-transplantation
#18
REVIEW
Anjali Nayak, Robert Ettenger, Katherine Wesseling-Perry
BACKGROUND: Recurrent disease after kidney transplant remains an important cause of allograft failure, accounting for 7-8% of graft loss and ranking as the fifth most common cause of allograft loss in the pediatric population. Although the pathophysiology of many recurrent diseases is incompletely understood, recent advances in basic science and therapeutics are improving outcomes and changing the course of several of these conditions. METHODS: Review of the literature...
May 2024: Pediatric Transplantation
https://read.qxmd.com/read/38650461/-sc-a-sc-multi-hierarchical-approach-reveals-sc-d-sc-serine-as-a-hidden-substrate-of-sodium-coupled-monocarboxylate-transporters
#19
JOURNAL ARTICLE
Pattama Wiriyasermkul, Satomi Moriyama, Masataka Suzuki, Pornparn Kongpracha, Nodoka Nakamae, Saki Takeshita, Yoko Tanaka, Akina Matsuda, Masaki Miyasaka, Kenji Hamase, Tomonori Kimura, Masashi Mita, Jumpei Sasabe, Shushi Nagamori
Transporter research primarily relies on the canonical substrates of well-established transporters. This approach has limitations when studying transporters for the low-abundant micromolecules, such as micronutrients, and may not reveal physiological functions of the transporters. While d-serine, a trace enantiomer of serine in the circulation, was discovered as an emerging biomarker of kidney function, its transport mechanisms in the periphery remain unknown. Here, using a multi-hierarchical approach from body fluids to molecules, combining multi-omics, cell-free synthetic biochemistry, and ex vivo transport analyses, we have identified two types of renal d-serine transport systems...
April 23, 2024: ELife
https://read.qxmd.com/read/38650418/-nephroprotective-value-of-n-acetylcysteine-for-patients-with-concomitant-trauma-as-well-as-other-aspects-of-the-use-of-this-drug-in-clinical-practice
#20
JOURNAL ARTICLE
A Miziev I, Kh Makhov M, B Makhova A, A Shiritova L, B Gubzhokova L
An analysis and review of domestic and foreign literature on the role of N-acetylcysteine in the correction of oxidative stress, as well as the problem of oxidative stress, and protection against free radicals are presented in the article. The important role of N-acetylcysteine in replenishing the intracellular glutathione level, which is the main cell antioxidant, has been shown, as well as the potential use of N-acetylcysteine for various pathological conditions and diseases. The relevance of concomitant injury and renal dysfunction, and the experience of the clinical use of N-acetylcysteine as a nephroprotector in patients with concomitant injury in the clinic of the Department of Faculty and Endoscopic Surgery of KBSU named after Kh...
March 2024: Urologii︠a︡
keyword
keyword
63057
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.